Drug Profile
Research programme: tuberculosis therapeutics - Indian Institute of Science/Vichem Chemie
Latest Information Update: 07 Jun 2022
Price :
$50
*
At a glance
- Originator Indian Institute of Science; Vichem Chemie
- Developer Hungarian Academy of Sciences; Indian Institute of Science; Vichem Chemie
- Class
- Mechanism of Action DNA topoisomerase inhibitors; Phosphatidyl myo inositol mannosyltransferase PimA inhibitors; Protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Tuberculosis
Most Recent Events
- 07 Jun 2022 Early research is ongoing in Hungary and India (Vichem Chemie pipeline, June 2022)
- 28 Apr 2019 No recent reports of development identified for research development in Tuberculosis in Hungary
- 28 Apr 2019 No recent reports of development identified for research development in Tuberculosis in India